A Milestone for Genomics in the St. Lucia: Caribbean Prostate Cancer Genetic Study & At-Home Genetic Tests Launch

The Caribbean took a bold step toward precision
medicine with the official launch of the Caribbean Prostate Cancer Genetic Study in Saint Lucia. This landmark event, hosted by GenTech Analytica, CariGenetics Limited, and
Laboratory Services and Consultations Limited, highlighted the urgent need for diverse
genetic data and innovation in healthcare across the region.

Keynote speakers underscored the transformative potential of genomics in addressing health disparities:
• Dr. Didacus Jules, Director General of the OECS, emphasized the importance of
collaboration in ensuring regional progress by stating “This is more than an unveiling, this is a rallying call for all of us to envision a future where science, technology FOR and community converge to redefine how we approach health
and wellness”

• Dr. Stephen King, a renowned healthcare advocate, emphasized the pillars of
success in decision-making: “Knowledge, faith, and courage. He stated, “We must
not allow Saint Lucia, the OECS, and the Caribbean to fall behind the rapid
advancements in health technology.”

• Dr. Carika Weldon, Founder & CEO of CariGenetics, shared her journey and vision:
“We are putting a stake in the ground and saying we are here, not just for the Caribbean but by the Caribbean. Together, we can ensure the Caribbean is no longer an afterthought in medical research but a leader in precision medicine.”

• Devy Frederick, Founder of GenTech Analytica, unveiled plans for 2025, stating, “GenTech Analytica believes in the transformative power of predictive modeling to revolutionize healthcare in the Caribbean. These advanced
technologies enable early detection and management of non-communicable diseases while providing critical insights into rare conditions, paving the way for a healthier future in our region.”

Prostate Cancer Study: A Milestone for Regional Health

Prostate cancer remains a critical health challenge in the Caribbean, particularly for men of African descent, who are disproportionately affected. The region bears some of the highest
prostate cancer incidence and mortality rates worldwide. In Jamaica, the incidence rate is
approximately 304 per 100,000 men annually, while in Barbados, it is about 160 per
100,000. These numbers are starkly higher compared to many global averages, with Afro-
Caribbean men facing an increased risk due to genetic predispositions, limited access to
early detection, and healthcare inequalities.
Despite these alarming statistics, the Caribbean remains underrepresented in global
genomic databases, which are predominantly Eurocentric. Currently, over 85% of genetic
data in major repositories is derived from individuals of European descent, creating a
significant gap in understanding the unique genetic factors affecting Caribbean populations.
This lack of representation hinders the development of effective, precision-based healthcare interventions tailored to the region’s needs.

Addressing these gaps requires urgent efforts to collect and analyze genetic data from
Caribbean populations. Initiatives such as the Caribbean Prostate Cancer Genetic Study
spearheaded by CariGenetics Limited in partnership with GenTech Analytica and
Laboratory Services and Consultations Limited are critical. This project, although launched
in Bermuda, will enroll 1000 men across 7-10 Caribbean islands in 2025. Saint Lucia is the
official second island to launch, with Antigua & Barbuda coming in February. This study
encourages men to take an active role in shaping the future of healthcare. Interested
participants in Saint Lucia can sign up via gentechanalytica.com/research.

Introducing Our At-Home Genetic Testing Kits
GenTech Analytica, the Official Product Partners for CariGenetics in St. Lucia, also
introduced at-home genetic testing kits designed to redefine how individuals approach
wellness. These kits provide personalized insights into fitness, nutrition, skin health,
personality traits, gut health, pharmacogenomics, and cannabis metabolism.
By analyzing an individual’s unique genetic makeup, these kits offer a science-based
explanation for why conventional routines and products often fall short, emphasizing that
wellness is not a one-size-fits-all solution. The results empower users to make informed
lifestyle and health decisions, offering tailored recommendations to optimize their well-being
and are easily accessible on their website.

Looking Ahead

This initiative marks the beginning of a larger movement to integrate precision medicine into
Caribbean healthcare. The organizers are committed to advancing research, expanding
accessibility through at-home genetic testing kits, and fostering collaborations that
strengthen the region’s health infrastructure.

Any content which is considered unsuitable, unlawful, or offensive, includes personal details, advertises or promotes products, services or websites, or repeats previous comments will be removed.

User comments posted on this website are solely the views and opinions of the comment writer and are not a representation of or reflection of the opinions of TNN or its staff.

TNN reserves the right to remove, edit or censor any comments.

TNN accepts no liability and will not be held accountable for the comments made by users.